Intrauterine Growth Restriction Clinical Trial
Official title:
Ultrasound Evaluation of Fetal Hemodynamics and Its Variations in Small Fetuses Looking for Prognostic Factors of Perinatal Complications
In case of fetal weight below the 10th centile for gestational age, it is important to
distinguish SGA and IUGR. SGA is defined as a fetal weight below the 10th centile. IUGR
correspond to a pathologic reduction of growth velocity and it is a major determinant of
perinatal mortality and morbidity. Even if SGA have long time been considered to be
constitutionally small without adverse outcomes, recent evidence has demonstrated that a
proportion of SGA, with normal UA Doppler, could be associated with neonatal adverse
outcomes, probably related to a late-onset IUGR. Therefore, it seems essential to
differentiate several categories of fetuses presenting abnormal fetal weight or intrauterine
growth: fetuses SGA without any Doppler abnormalities, fetuses affected by early or
late-IUGR. In case of late-IUGR, an important part of these fetuses is initially considered
as PAG with a normal umbilical Doppler.
In case of fetal weight below the 10th centile for gestational age, longitudinal assessment
of the fetal weight and umbilical artery (UA) Doppler is recommended. In case of abnormal UA
Doppler, Middle Cerebral Artery (MCA) Doppler is recommended to research a "brain-sparing"
effect. If UA and MCA Doppler findings seem to become abnormal in the early stages of IUGR,
Ductus Venosus (DV) flow abnormalities have been described as a late marker of fetal
decompensation related to an acute myocardial impaired relaxation and acidemia which is a
major contributor to adverse perinatal outcome and neurological. The aortic isthmus (AoI)
Doppler is an indicator of the progression of fetal hemodynamic deterioration in IUGR and
recent data confirm that AoI and DV abnormalities are correlated but AoI Doppler
abnormalities would occur earlier than DV Doppler. AoI Doppler could identify abnormalities
suggestive of right ventricular dysfunction before DV Doppler and anticipate obstetrical
management. In conclusion, Doppler examination could not be reduced to UA Doppler in case of
SGA and IUGR and require a global examination including MCA and probably DV and AoI Doppler.
That's why fetal growth assessment should not be limited to fetal biometry and umbilical
artery Doppler. Thanks to a systematic protocol for Doppler examination based on UA, MCA, DV
and Aortic Isthmus (AoI) Doppler, we hope identify these hemodynamic variations in a large
cohort of fetuses <10 to improve prenatal assessment of these foetus to and perinatal
outcomes, reducing perinatal morbi-mortality.
All women were followed at one referent matron-fetal medicine unit where they delivered or to
which they were referred for abnormalities of the fetal growth. Conforming to national
guidelines, referent ultrasound scans and longitudinal assessment of the estimated fetal
weight (EFW) were performed depending on the EFW. Each eligible woman was given an
information sheet concerning the study protocol.
Fetal biometry and Doppler were performed thanks to a standardised protocol based on
international guidelines. In all instances, ultrasound examinations were performed by one
experienced and certified operators using an ultrasound machine (GE Voluson E8/E10, GE
Medical Systems). EFW was calculated from head and abdominal circumferences and femur length
using the formula of Hadlock. The reference growth curves was CFEF growth curves.
Pulsed Doppler measurements were performed automatically, based on at least three consecutive
waveforms, with angle of insonation as close to 0° as possible and always below 30°. A
high-pass filter of 70 Hz was used to record low-flow velocities and to avoid artifacts. The
Umbilical Artery (UA)-PI Doppler were measured at the placental insertion of the funicular
cord. The Middle Cerebral Artery (MCA)-PI was obtained in a transverse view of the fetal
head, at the level of its origin from the circle of Willis, and the cerebroplacental ratio
(CPR) was calculated as the ratio MCA-PI / UA-PI. Aortic Isthmus (AoI)-PI was measured at the
level of the three vessels and trachea view, placing the gate just before the convergence of
the AoI and the arterial duct. Ductus Venosus (DV)-PI was measured in a mid-sagittal or
transverse section of the fetal abdomen, positioning the Doppler gate at its isthmic portion.
Participation in the study does not lead to any change in practices or additional data.
In order to ensure the reproducibility of the data and to limit the measurement biases, we
will perform a second reading of the Doppler to verify the application of the measurement
protocol, especially: acquisition, Doppler spectrum and measurements. A first analysis will
focus on the first 10 patients included per center and then, a random analysis on 10 patients
every 100 patients included.
Regularly, data monitoring will be made by a scientific technician to reduce missing data.
Anonymous sonographic data were automatically extracted from the electronic patient record
(Diamm (MICRO6 SARL) or ViewPoint (General Electric Healthcare France)) and compiled into an
electronic case report form with demographic, maternal, obstetrical and neonatal data.
Regular extraction will allow to test extraction pipeline and statistical test.
Given a 10% prevalence of SGA, an expected inclusion rate with completed data of 90% and the
number of births in the several units, a sample size of 1200 newborns was sufficient to
identify 20% of adverse perinatal outcome.
Quantitative variables will be described using the following parameters: mean, standard
deviation, median, and minimum and maximum values. Qualitative variables will be described by
the frequency and proportion of each class. The qualitative variables will be compared by
Chi² test or Fisher exact test. Quantitative variables will be compared by a Student test or
a Mann & Whitney test. We will focus on describing the temporal dynamics of the
cerebro-aortic relationship.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04506970 -
Predicting Placental Pathologies by Ultrasound Imaging
|
||
Recruiting |
NCT03866863 -
Intra Uterine Growth Restriction
|
||
Recruiting |
NCT03662178 -
Investigating the Structured Use of Ultrasound Scanning for Fetal Growth
|
||
Not yet recruiting |
NCT05720169 -
Fetal, Obstetrics and Reproduction Genomics
|
||
Completed |
NCT04633551 -
Vascular Inflammation and Anti-inflammatory Supplements After Adverse Pregnancy Outcomes
|
N/A | |
Recruiting |
NCT05500989 -
PlacEntal Acute Atherosis RefLecting Subclinical Atherosclerosis
|
||
Recruiting |
NCT04141189 -
Comparison of Follow-up Protocols in Terms of Fetal, Neonatal and Maternal Results in Intrauterine Growth Retardation
|
N/A | |
Completed |
NCT03726697 -
Effect of Tahneek on Hypoglycemia in Newborn Infants
|
N/A | |
Recruiting |
NCT03398629 -
Diagnosis and Management of Intrauterine Growth Restriction and Congenital Anomalies
|
||
Recruiting |
NCT02473991 -
Correlation Between Placental Thickness in the Second and Third Trimester and Fetal Weight
|
N/A | |
Completed |
NCT02696577 -
The Effect of Omega 3 on Pregnancy Complicated by Asymmetrical Intrauterine Growth Restriction
|
Phase 2 | |
Recruiting |
NCT04766866 -
sFlt1/PlGF and Planned Delivery to Prevent Preeclampsia at Term.
|
N/A | |
Terminated |
NCT04047966 -
Study of the Fetal and Maternal Microbiota in Preganant Women With Fetal Defect Growth
|
||
Completed |
NCT05328453 -
Sonographic 3D Measurement of Fetal Thymus May be Used to Predict the Small Baby in Pregnancy.
|
||
Completed |
NCT05800938 -
The Effect of Oral Isosorbide Mononitrate Therapy on Umbilical Artery Doppler Resistance Index in Pregnancies With Intrauterine Growth Restriction: Prospective Randomized Control Trial
|
Phase 4 | |
Not yet recruiting |
NCT06226051 -
Growing Little PEAPODS Study
|
||
Recruiting |
NCT02807324 -
Women Specific Cardiac Recovery After Preeclampsia
|
||
Recruiting |
NCT02515292 -
Evaluation of Infants With Intrauterine Growth Restriction
|
N/A | |
Active, not recruiting |
NCT01942525 -
Influence of Intrauterine Growth Restriction on Amplitude-integrated EEG in Preterm Infants
|
N/A | |
Withdrawn |
NCT04557475 -
Transplacental Aspirin Therapy for Early Onset Fetal Growth Restriction
|
Phase 3 |